Vascular damage after photodynamic therapy of solid tumors: A view and comparison of effect in pre-clinical and clinical models at the Univeristy of Louisville

In Vivo

Volumn 14, Issue 1, 2000, Pages 93-100

  Fingar, Victor H ^a   Taber, Scott W ^a   Haydon, Pamela S ^a   Harrison, Linda T ^a   Kempf, Stephen J ^a   Wieman, T Jeffery ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Microvasculature; Photodynamic therapy; Photofrin; Photosensitizers; Tumor; Vascular damage

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; FIBRONECTIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE;

ANIMAL MODEL; BLOOD VESSEL DIAMETER; BLOOD VESSEL INJURY; BLOOD VESSEL PARAMETERS; BREAST CANCER; CELL ADHESION; CHONDROSARCOMA; CYTOTOXICITY; HUMAN; MICROVASCULATURE; NONHUMAN; PHOTODYNAMIC THERAPY; RESPONSE TIME; REVIEW; SOLID TUMOR; THROMBOCYTOPENIA; TISSUE NECROSIS; TISSUE PERFUSION; TUMOR NECROSIS; VASCULAR ENDOTHELIUM; VENOUS STASIS;

EID: 0034112132     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q. Photodynamic Therapy. J Natl Cancer Inst 90: 889-905, 1998.
2. Figge FHJ: Near-ultraviolet rays and fluorescence phenomena as aids to discovery and diagnosis in medicine. Bull Sch Med Univ Md 26: 165-176, 1942.
3. 14C]-Hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 39: 146-151, 1979.
4. Dougherty TJ, Grindey GL, Fiel R, et al: Photoradiation therapy II Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 55: 115, 1975.
5. Henderson BW, Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 55(1): 145-157, 1992.
6. Fingar VH, Wieman TJ, Karavolos PS, Doak KW, Ouellet R, van Lier, JE: The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response. Photochem Photobiol 58: 251-258, 1993.
7. Henderson BW, Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 55(1): 145-157, 1992.
8. Cincotta L, Szeto D, Lampros E, Hasan T, Cincotta AH: Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem Photobiol 63(2): 229-238, 1996.
9. Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB: The role of microvascular damage in photodynamic therapy: The effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res 52: 4914-4921, 1992.
10. Hausmann W: Die sensibilisierende wirkung des hematoporphyrins. Biochem Z 30: 276-316, 1911.
11. Roberts DJH, Cairnduff F, Driver I, Dixon B, Brown SB: Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolaevulinic acid. Int J Oncol 5: 763-768, 1994.
12. Siegel KA, Wieman TJ, Fingar VH: The effects of photodynamic therapy using mono-1-aspartyl chlorin e6 on vessel constriction, vessel leakage and tumor response. Cancer Research 54: 5374-5379, 1994.
13. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, Haimovici R, Gragoudas ES: Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 113(6): 810-818, 1995.
14. Gottfried V, Davidi R, Averguj C, Kimel S: In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy. J Photochem Photobiol B 30(2-3): 115-121, 1995.
15. Morgan AR, Garbo GM, Keck RW, Eriksen LD, Selman SH: Metallopurpurins and light: Effect on transplantable rat bladder tumors and murine skin. Photochem Photobiol 51: 589-592, 1990.
16. Henderson BW, Fingar VH: Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47: 3110-3114, 1987.
17. Henderson BW, Fingar VH: Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model. Photochem Photobiol 49(3): 299-304, 1989.
18. Star WM, Marijnissen HPA, van den Berg-Blok S, Versteeg JAC, Franken KAP: Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 46: 2532-3540, 1986.
19. Selman SH, Kreimer-Birnbaum M, Goldblatt PJ, Keck RW, Britton SL: Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res 44: 1924-1927 1984.
20. Reed MWR, Wieman TJ, Schuschke DA, Tsent MT, Miller FN: A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculaion. Radiat Res 119: 542-552, 1989.
21. Reed MWR, Miller, FN, Wieman TJ, Tseng MT, Pietsch CG: The effect of photodynamic therapy on the microcirculation. J Surg Res 45: 452-459, 1988.
22. Ben-Hur E, Heldman E, Crane SE, Rosenthal I: Release of clotting factors from photosensitized endothelial cells: a possible trigger for blood vessel occlusion by photodynamic therapy. FEBS Lett 236(1): 105-108, 1988.
23. Foster TH, Primavera MC, Marder VH, Hilf R, Sporn LA: Photosensitized release of von Willebrand factor from cultured human endothelial cells. Cancel Res 51: 3261-3266, 1991.
24. Dadosh N, Shaklai N: Impairment of red cell membrane cytoskeleton by protoporphyrin-IX: light and dark effects. Photochem Photobiol 47: 689-697, 1988.
25. Boekelheide, KJ, Eveleth J, Tatum AH, Winkelman JW: Microtubule assembly inhibited by porphyrins and related compounds. Photochem Photobiol 47: 657-661, 1987.
26. Sporn LA, Foster TH: Photofrin and light induces microtubule depolymerization in cultured human endothelial cells. Cancer Res 52: 3443-3448, 1992.
27. Wicman TJ, Doak KD, Fingar VH: Effects of PDT on cytoskeletal F-actin structures. Photochem Photobiol 53(S): 96S-97S, 1991.
28. Nelson JS, Liaw LH, Berns MW: Tumor destruction in photodynamic therapy. Photochem Photobiol 46: 829-835, 1987.
29. Doukas J, Hechtman HB, Shepro D: Vasoactive amines and eicosanoids interactively regulate both polymorphonuclear leukocyte diapedesis and albumin permeability in vitro. Microvasc Res 37: 125-137, 1989.
30. Nicolson GL, Custead SE: Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity. Cancer Res 45: 331-336, 1985.
31. Welles SL, Shepro D, Hechtman HB: Eicosanoid modulation of stress fibers in cultured bovine endothelial cells. Inflammation 9: 439-450, 1985.
32. Bellnier DA, Dougherty TJ: The time course of cutaneous porphyrin photosensitization in the murine ear. Photochem Photobiol 49: 369-372, 1989.
33. West CML, West DC, Kumar S, Moore JV: A comparison of the sensitivity to photodynamic treatment of endothelial and tumor cells in different proliferative states. Int J Radiation 58(1): 145-156, 1990.
34. Leunig, A, Staub, F, Peters, J, Jeimann, A, Csapo, C, Kempski, O, Gotz, and AE: Relation of early Photofrin uptake to photodynamically induced phototoxicity and changes of cell volume in different cell lines. European Journal of Cancer 30A: 78-83, 1994.
35. Gomer CJ, Rucker N, Murphree AL: Differential Cell Photosensitivity following Porphyrin Photodynamic Therapy. Cancer Research 48: 4539-4542, 1988.
36. Roberts WG, Hasan T: Role of neovasculatureand vascular permeability on the tumor retention of photodynamic agents. Cancer Res 52: 924-930, 1992.
37. Roberts WG, Hasan T: Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Cancer Research 53(1): 153-157, 1993.
38. Henderson BW, Vaughan L, Bellnier DA, van Leengoed H, Johnson PG, Oseroff AR: Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem Photobiol 62(4): 780-789, 1995.
39. Bugelski PJ, Porter CW, Dougherty TJ: Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res 41: 4606-4612, 1981.
40. Sitnik TM, Henderson BW: Fluence rate dependence of tumor oxygenation during photodynamic therapy. Photochem Photobiol 63(S), 71(S), 1996.
41. Seifalian AM, Chaloupka K, Parbhoo SP: Laser doppler perfusion imaging a new technique for measuring breast skin blood flow. Int J Microcirc 15: 125-30, 1995.
42. Brasseur N, Lewis K, Rousseau J, van Lier JE: Measurement of tumor vascular damage in mice with 99mTc-MIBI following photodynamic therapy. Photochem Photobiol 64: 702-706, 1996.
43. Moore RB, Chapman JD, Mercer JR, Mannan RH, Wiebe LI, McEwan AJ, McPhee MS: Measurement of PDT-induecd hypoxia in dunning prostate tumors by iodine-123-iodoazomycin arabinoside. Joural of Nuclear Medicine 34: 405-411, 1993.
44. Chen Q, Chen H, Hetzel FW: Tumor oxygenation changes post-photodynamic therapy. Photochem Photobiol 63(1): 128-131, 1996.
45. Jakobsson AJ, Nilsson GE: Prediction of sampling depth and photon pathlength in laser doppler flowmetry. Medical and Biological Enginering and Computing 301-307, 1993.
46. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjoppoulos D, Jain RK: Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54: 3352-3356, 1994.
47. Anderson C, Andersson T, Wardell K: Changes in skin circulation after insertion of a microdialysis probe visualized by laser doppler perfusion imaging. J Invest Dermatology 102: 807-811, 1994.
48. Wang I, Andersson-Engels S, Nelsson GE, Wardell K, Svanberg K: Superficial blood flow following photodynamic therapy of malignant non-melanoma skin tumours measured by laser doppler perfusion imaging. British Journal of Dermatology 136: 184-189, 1997.